ANI PHARMACEUTICALS INC — Director's Dealing 2016

Aug 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-08-22

Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-22	Common Stock	M	24705	$6.36	Acquired	200788	Direct
2016-08-22	Common Stock	M	15723	$6.36	Acquired	216511	Direct
2016-08-22	Common Stock	M	12750	$33.00	Acquired	229261	Direct
2016-08-22	Common Stock	S	37455	$66.97	Disposed	191806	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-22	Stock Options	$6.36	M	24705	Acquired	2023-07-11	Common Stock (24705)	Direct
2016-08-22	Stock Options	$6.36	M	15723	Acquired	2023-07-11	Common Stock (15723)	Direct
2016-08-22	Stock Options	$33.00	M	12750	Acquired	2024-03-31	Common Stock (12750)	Direct

Footnotes

F1: The reported price is a weighted average sale price for multiple sale transactions ranging from a low sale price of $66.70 to a high sale price of $67.57. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request from the staff of the Securities and Exchange Commission, the Issuer or a stockholder of the Issuer.